PHILADELPHIA, March 29, 2017 -- Rittenhouse Realty Advisors and Rittenhouse Capital Advisors are pleased to announce new additions to their teams for 2017.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/50c146b5-8515-485a-ad02-fe163a91a998.
Nabila Nanji has joined Rittenhouse Realty Advisors as a Marketing Specialist, bringing with her ten years of commercial real estate experience, including investment sales, retail leasing, and marketing. Following her graduation from the University of Texas, Nabila worked as an investment sales associate in the Dallas/Fort Worth and Austin markets and has since worked in commercial lending as well as with a national brokerage firm in business development and operations. At RRA, Nabila is focusing on business development, operations, and market research with goals to expand the company’s presence in local and regional markets.
Rittenhouse Capital Advisors welcomed Sam Oropeza, who is directing business development and client management. Sam works with local developers and property owners in the Philadelphia MSA to assist them in achieving their goals for their projects and portfolios. He has hands on experience in real estate construction and development, having recently served as Supervisor of Facility Maintenance for Johnson & Johnson. Sam brings a unique set of talents and tenacity to his Business Development role with RCA, as he recently fulfilled a life-long goal and became a professional athlete, participating in the MMA arena. He wrapped up a successful career with a 13-3 record spanning from 2009 to 2015.
George Johnson, President & CEO of Rittenhouse Capital Advisors stated: “Sam’s honest and genuine approach has allowed him to build strong relationships with real estate brokers, developers, and property owners throughout the Philadelphia market. He will be a major contributor to the future growth of Rittenhouse Capital.” Corey Lonberger, Managing Partner at Rittenhouse Realty Advisors, added: “We are very excited about the additions of Nabila and Sam to the RRA and RCA family. We are confident that they will add to the continued growth and success of our companies.”
Based in Philadelphia, Pennsylvania, Rittenhouse Realty Advisors is a real estate advisory firm with an extensive focus in the brokerage of multi-family communities throughout the northeast region of the United States. Formed in February 2013 by a group of advisors with more than 30 years of commercial investment sales experience, our focus is on multi-family and mixed-use properties with significant residential components.
www.RittenhouseRealty.com
Press Contact: Corey Lonberger and Ken Wellar Managing Partners 215-454-2852


Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration 



